RT Journal Article
SR Electronic
T1 Objective Olfactory Evaluation of Self-reported Loss of Smell in a Case Series of 86 COVID-19 Patients
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.03.20088526
DO 10.1101/2020.05.03.20088526
A1 Lechien, Jerome R.
A1 Cabaraux, Pierre
A1 Chiesa-Estomba, Carlos M.
A1 Khalife, Mohamad
A1 Hans, Stéphane
A1 Calvo-Henriquez, Christian
A1 Martiny, Delphine
A1 Journe, Fabrice
A1 Sowerby, Leigh
A1 Saussez, Sven
YR 2020
UL http://medrxiv.org/content/early/2020/05/08/2020.05.03.20088526.abstract
AB Objective To investigate olfactory dysfunction (OD) in patients with mild COVID-19 through patient-reported outcome questionnaires and objective psychophysical testing.Methods COVID-19 patients with self-reported sudden-onset OD were recruited. Epidemiological and clinical data were collected. Nasal complaints were evaluated with the sino-nasal outcome-22 (SNOT-22). Subjective olfactory and gustatory status was evaluated with the National Health and Nutrition Examination Survey (NHNES). Objective OD was evaluated using psychophysical tests.Results Eighty-six patients completed the study. The most common symptoms were fatigue (72.9%), headache (60.0%), nasal obstruction (58.6%) and postnasal drip (48.6%). Total loss of smell was self-reported by 61.4% of patients. Objective olfactory testings identified 41 anosmic (47.7%), 12 hyposmic (14.0%), and 33 normosmic (38.3%) patients. There was no correlation between the objective test results and subjective reports of nasal obstruction or postnasal drip.Conclusion A significant proportion of COVID-19 patients reporting OD do not have OD on objective testing.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFRMH Funding.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are available on demand.